Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Hizentra in Primary Immunodeficiency
NCT00719680Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jun 2008
- Primary completion
- Jun 2010
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Jun 2008; status: completed.
02
Drugs
IgPro10
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT00719680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719680.